Enter assignee name

Forward Citations = 9

where 'Filed Patents' based on already Granted Patents

where 'Inventors Filed' based on already Granted Patents

25 inventors (with patents filed for the assignee):

Hiroshi Saito (1 out of 75 patents)

Shoji Shibata (1 out of 2 patents)

Takako Yokozawa (1 out of 2 patents)

4. Fujio Suzuki (1 out of 10 patents)

5. Makiko Kobayashi (1 out of 3 patents)

6. Tokuichiro Utsunomiya (1 out of 1 patent)

7. Hiroatsu Matsumoto (1 out of 1 patent)

8. Midori Takeda (1 out of 1 patent)

9. Shigemi Iwata (1 out of 1 patent)

10. Yasunobu Antoku (1 out of 2 patents)

11. Kosuke Tsukamoto (1 out of 2 patents)

12. Fumihiko Koike (1 out of 2 patents)

13. Masahiro Nakano (1 out of 3 patents)

14. Hikokichi Oura (1 out of 1 patent)

15. Itsuo Nishioka (1 out of 4 patents)

5 patents: Sort by Forward Citations

1. 7015202 - Use of glycyrrhizin and its derivatives as MCP-1 production inhibitors (2006-03-21),

2. 5622942 - Percutaneous absorptive anesthetic (1997-04-22),

3. 5434142 - Method of treatment for muscular dystrophy (1995-07-18),

4. 5358962 - Antihypertensive method (1994-10-25),

5. 4374284 - Antiulcer, antiinflammatory, and antiallergic agent comprising as the (1983-02-15),

Minophagen Pharmaceutical Co., Ltd. is a leading Japanese pharmaceutical company specializing in the development of innovative drugs for liver diseases. With a strong focus on research and development, Minophagen is committed to improving the quality of life for patients suffering from liver-related conditions. The company's dedication to excellence and cutting-edge technology has earned them a reputation for producing high-quality pharmaceutical products.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 2 2025

5 Patents

#2,448 in Tokyo

#6,485 in Japan

Tokyo, Japan

Minophagen Pharmaceutical Co., Ltd.